Enliven Therapeutics (ELVN) Tax Rate (2024)
Enliven Therapeutics' (ELVN) quarterly Tax Rate came in at 1.13% in Q2 2024.
Enliven Therapeutics (ELVN) Tax Rate (2024) Analysis & Trends
Enliven Therapeutics has disclosed Tax Rate across 1 years of filings, most recently posting 1.13% for Q2 2024.
- Tax Rate for Q2 2024 came in at 1.13%, changed N/A year-over-year; the trailing twelve-month figure through Jun 2025 was 0.23% (changed N/A YoY), and the FY2024 annual result was 0.26%, changed N/A from the prior year.
- Tax Rate came in at 1.13% for Q2 2024 at Enliven Therapeutics.
- In the past five years, Tax Rate ranged from a high of 1.13% in Q2 2024 to a low of 1.13% in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -57.14% |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 5.61% |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | -6.79% |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 17.68% |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Enliven Therapeutics | 2.32 Bn | 2.32 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -1.13% |
| Jun 30, 2024 | -1.13% |